Benzinga's Top Upgrades, Downgrades For July 29, 2020

In this article:

Upgrades

  • For Safe Bulkers Inc (NYSE: SB), DNB Markets upgraded the previous rating of Hold to the current rating Buy. For the first quarter, Safe Bulkers had an EPS of ($0.13), compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $2.25 and a 52-week-low of $0.74. At the end of the last trading period, Safe Bulkers closed at $1.21.

  • According to SunTrust Robinson Humphrey, the prior rating for Tenable Holdings Inc (NASDAQ: TENB) was changed from Hold to Buy. For the second quarter, Tenable Holdings had an EPS of $0.04, compared to year-ago quarter EPS of ($0.10). The current stock performance of Tenable Holdings shows a 52-week-high of $32.15 and a 52-week-low of $16.28. Moreover, at the end of the last trading period, the closing price was at $30.37.

  • B of A Securities upgraded the previous rating for U.S. Xpress Enterprises Inc (NYSE: USX) from Neutral to Buy. In the second quarter, U.S. Xpress Enterprises showed an EPS of $0.18, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $7.63 and a 52-week-low of $2.65. At the end of the last trading period, U.S. Xpress Enterprises closed at $6.78.

  • For Zynex Inc (NASDAQ: ZYXI), B. Riley FBR upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Zynex showed an EPS of $0.09, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.73 and a 52-week-low of $7.51. Zynex closed at $18.51 at the end of the last trading period.

  • For Arlo Technologies Inc (NYSE: ARLO), Raymond James upgraded the previous rating of Market Perform to the current rating Outperform. Arlo Technologies earned ($0.34) in the first quarter, compared to ($0.47) in the year-ago quarter. The stock has a 52-week-high of $5.13 and a 52-week-low of $1.20. At the end of the last trading period, Arlo Technologies closed at $3.29.

  • According to Rosenblatt, the prior rating for Rockwell Automation Inc (NYSE: ROK) was changed from Sell to Neutral. In the third quarter, Rockwell Automation showed an EPS of $1.27, compared to $2.40 from the year-ago quarter. The stock has a 52-week-high of $230.93 and a 52-week-low of $115.38. At the end of the last trading period, Rockwell Automation closed at $222.25.

  • For Quest Diagnostics Inc (NYSE: DGX), KeyBanc upgraded the previous rating of Sector Weight to the current rating Overweight. For the second quarter, Quest Diagnostics had an EPS of $1.42, compared to year-ago quarter EPS of $1.73. At the moment, the stock has a 52-week-high of $131.81 and a 52-week-low of $73.02. Quest Diagnostics closed at $123.50 at the end of the last trading period.

 

Downgrades

  • For Align Technology Inc (NASDAQ: ALGN), Berenberg downgraded the previous rating of Buy to the current rating Hold. Align Tech earned ($0.35) in the second quarter, compared to $1.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $326.36 and a 52-week-low of $127.88. Align Tech closed at $299.11 at the end of the last trading period.

  • For Armstrong World Industries Inc (NYSE: AWI), Evercore ISI Group downgraded the previous rating of In-Line to the current rating Underperform. Armstrong World Indus earned $0.75 in the second quarter, compared to $1.27 in the year-ago quarter. The current stock performance of Armstrong World Indus shows a 52-week-high of $111.46 and a 52-week-low of $62.03. Moreover, at the end of the last trading period, the closing price was at $72.00.

  • For National CineMedia Inc (NASDAQ: NCMI), Wedbush downgraded the previous rating of Outperform to the current rating Neutral. National CineMedia earned ($0.05) in the first quarter, compared to ($0.01) in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.85 and a 52-week-low of $1.62. National CineMedia closed at $2.94 at the end of the last trading period.

  • Raymond James downgraded the previous rating for Sonos Inc (NASDAQ: SONO) from Strong Buy to Market Perform. In the second quarter, Sonos showed an EPS of ($0.48), compared to ($0.22) from the year-ago quarter. The current stock performance of Sonos shows a 52-week-high of $17.83 and a 52-week-low of $6.58. Moreover, at the end of the last trading period, the closing price was at $16.45.

  • According to RBC Capital, the prior rating for T-Mobile US Inc (NASDAQ: TMUS) was changed from Outperform to Sector Perform. In the first quarter, T-Mobile US showed an EPS of $1.10, compared to $1.06 from the year-ago quarter. The stock has a 52-week-high of $111.58 and a 52-week-low of $63.50. At the end of the last trading period, T-Mobile US closed at $104.52.

  • According to Benchmark, the prior rating for Seagate Technology PLC (NASDAQ: STX) was changed from Buy to Hold. For the fourth quarter, Seagate Technology had an EPS of $1.20, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $64.17 and a 52-week-low of $39.02. Seagate Technology closed at $48.57 at the end of the last trading period.

  • Bernstein downgraded the previous rating for ASML Holding NV (NASDAQ: ASML) from Outperform to Market Perform. ASML Holding earned $1.97 in the second quarter, compared to $1.27 in the year-ago quarter. The stock has a 52-week-high of $402.87 and a 52-week-low of $191.25. At the end of the last trading period, ASML Holding closed at $376.36.

 

Initiations

  • Oppenheimer initiated coverage on Bill.com Holdings Inc (NYSE: BILL) with an Outperform rating. The price target for Bill.com Holdings is set to $103.00. In the first quarter, Bill.com Holdings earned ($0.04). The current stock performance of Bill.com Holdings shows a 52-week-high of $97.84 and a 52-week-low of $23.61. Moreover, at the end of the last trading period, the closing price was at $85.05.

  • With a current rating of Outperform, Credit Suisse initiated coverage on Flexion Therapeutics Inc (NASDAQ: FLXN). The price target seems to have been set at $19.00 for Flexion Therapeutics. Flexion Therapeutics earned ($0.95) in the first quarter, compared to ($1.09) in the year-ago quarter. The current stock performance of Flexion Therapeutics shows a 52-week-high of $22.98 and a 52-week-low of $5.01. Moreover, at the end of the last trading period, the closing price was at $12.49.

  • Evercore ISI Group initiated coverage on Principia Biopharma Inc (NASDAQ: PRNB) with an Outperform rating. The price target for Principia Biopharma is set to $130.00. In the first quarter, Principia Biopharma showed an EPS of ($0.99), compared to ($0.57) from the year-ago quarter. At the moment, the stock has a 52-week-high of $94.91 and a 52-week-low of $25.35. Principia Biopharma closed at $84.39 at the end of the last trading period.

  • With a current rating of Buy, Deutsche Bank initiated coverage on T-Mobile US Inc (NASDAQ: TMUS). The price target seems to have been set at $140.00 for T-Mobile US. For the first quarter, T-Mobile US had an EPS of $1.10, compared to year-ago quarter EPS of $1.06. The current stock performance of T-Mobile US shows a 52-week-high of $111.58 and a 52-week-low of $63.50. Moreover, at the end of the last trading period, the closing price was at $104.52.

  • Guggenheim initiated coverage on Protara Therapeutics Inc (NASDAQ: TARA) with a Buy rating. The price target for Protara Therapeutics is set to $50.00. Protara Therapeutics earned ($1.81) in the first quarter, compared to ($0.58) in the year-ago quarter. At the moment, the stock has a 52-week-high of $67.08 and a 52-week-low of $19.22. Protara Therapeutics closed at $27.45 at the end of the last trading period.

  • HC Wainwright & Co. initiated coverage on argenx SE (NASDAQ: ARGX) with a Neutral rating. The price target for argenx is set to $272.00. In the first quarter, argenx showed an EPS of ($2.06), compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $272.74 and a 52-week-low of $103.75. argenx closed at $253.23 at the end of the last trading period.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement